Zvi Schreiber reports multiple CRGO share sales (NASDAQ: CRGO)

Rhea-AI Filing Summary

Zvi Schreiber reported multiple sales of Ordinary shares on a Form 144. The filings list discrete disposals between 03/11/2026 and 05/11/2026, including 20,000 shares on 05/11/2026 for $41,017.45 and several 20,000-share entries on earlier dates. The record also lists 30,699 Restricted Stock Units with an original grant date of 09/06/2023.

Insights

Insider Transactions Analyst

Multiple rule‑144 dispositions reported by Zvi Schreiber across March–May 2026.

The excerpt lists numerous discrete sales of Ordinary shares between 03/11/2026 and 05/11/2026, with line items such as 20,000 shares for $41,017.45 on 05/11/2026. It also shows Restricted Stock Units granted on 09/06/2023 totaling 30,699.

Cash‑flow treatment is not detailed beyond per‑trade proceeds; timing and aggregation are explicit per trade. Subsequent filings or broker records would be needed to confirm whether these represent Rule 144 routine dispositions or transfers through other mechanisms.

Key Figures

Sale on 05/11/2026: 20,000 shares Sale on 05/06/2026: 20,000 shares Sale on 04/28/2026: 15,000 shares +2 more

5 metrics

Sale on 05/11/2026 20,000 shares sold for <money>$41,017.45</money> on <date>05/11/2026</date>

Sale on 05/06/2026 20,000 shares sold for <money>$41,000.00</money> on <date>05/06/2026</date>

Sale on 04/28/2026 15,000 shares sold for <money>$30,750.00</money> on <date>04/28/2026</date>

Restricted Stock Units (grant) 30,699 RSUs granted on <date>09/06/2023</date>

Earliest listed sale in excerpt 5,000 shares sold for <money>$6,300.00</money> on <date>03/11/2026</date>

Key Terms

Form 144, Restricted Stock Units, Ordinary

3 terms

Form 144 regulatory

"listed multiple sales on discrete dates between 03/11/2026 and 05/11/2026"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 30699 | 09/06/2023"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Ordinary market

"Ordinary | Oppenheimer& Co. Inc 85 Broad St. New York NY 10004"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 08:56 AM Learn about SEC filing dates

FAQ

What sales did Zvi Schreiber report for CRGO on this Form 144?

The filing lists multiple share disposals between 03/11/2026 and 05/11/2026, including 20,000 shares on 05/11/2026 for $41,017.45. Several other transactions show 5,000–20,000 share lots with per‑trade proceeds listed.

Does the filing show any Restricted Stock Units for CRGO?

Yes. The excerpt lists Restricted Stock Units with a grant date of 09/06/2023 and a quantity of 30,699. The entry labels these as issuer‑granted RSUs in the securities section.

Over what dates do the reported CRGO transactions occur?

The transactions reported span from 03/11/2026 through 05/11/2026, with multiple entries in March, April, and May 2026 showing specific share counts and proceeds for each trade.

Are aggregate proceeds or a total number of shares sold provided in the excerpt?

The excerpt provides per‑trade share counts and dollar proceeds for each listed date (for example, 20,000 shares for $41,017.45 on 05/11/2026). It does not present a single aggregated total in the visible text.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer& Co. Inc 85 Broad St. New York NY 10004	25000	53750.00	51376890	05/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	09/06/2023	Restricted Stock Units	Issuer			30699	09/06/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Zvi Schreiber PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/11/2026	20000	41017.45
Zvi Schreiber PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/06/2026	20000	41000.00
Zvi Schreiber PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/04/2026	20000	41000.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/28/2026	15000	30750.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/17/2026	10000	21300.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/15/2026	10000	18500.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/13/2026	10000	16200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/08/2026	10000	16900.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/01/2026	5000	8200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/30/2026	5000	8150.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/24/2026	10000	15850.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/17/2026	10000	16508.50
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/16/2026	10000	15214.04
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA, BARCELONA U3 08018	Ordinary	03/11/2026	5000	6300.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)